AADACL3
Arylacetamide deacetylase-like 3
Also known as: ADCL3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VUY0
- Gene
- AADACL3
- Ensembl
- ENSG00000188984
- Chromosome
- 1
- Canonical length
- 407 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable carboxylic ester hydrolase activity. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
407 residues, UniProt reviewed canonical sequence.
>Q5VUY0|AADACL3
1 MWDLALIFLA AACVFSLGVT LWVICSHFFT VHIPAAVGHP VKLRVLHCIF QLLLTWGMIF
61 EKLRICSMPQ FFCFMQDLPP LKYDPDVVVT DFRFGTIPVK LYQPKASTCT LKPGIVYYHG
121 GGGVMGSLKT HHGICSRLCK ESDSVVLAVG YRKLPKHKFP VPVRDCLVAT IHFLKSLDAY
181 GVDPARVVVC GDSFGGAIAA VVCQQLVDRP DLPRIRAQIL IYAILQALDL QTPSFQQRKN
241 IPLLTWSFIC YFFFQNLDFS SSWQEVIMKG AHLPAEVWEK YRKWLGPENI PERFKERGYQ
301 LKPHEPMNEA AYLEVSVVLD VMCSPLIAED DIVSQLPETC IVSCEYDALR DNSLLYKKRL
361 EDLGVPVTWH HMEDGFHGVL RTIDMSFLHF PCSMRILSAL VQFVKGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AADACL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 3 nTPM
Expression across tissuesHPA
Tissue
- skin: 3 nTPM
- placenta: 1.5 nTPM
- breast: 0.7 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- extravillous trophoblasts: 4.3 nCPM
- early spermatids: 1.1 nCPM
- late primary spermatocytes: 0.7 nCPM
- foveolar cells: 0.4 nCPM
- mast cells: 0.3 nCPM
- neutrophil progenitors: 0.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.34
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AADACL3 as an antibody target. Whether an autoantibody or antibody against AADACL3 could matter depends on whether native AADACL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AADACL3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AADACL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...